Extending human healthspan by 30+ years

Boris Djordjevic is a visionary entrepreneur and biotechnology pioneer who is redefining the boundaries of human longevity. As the founder and CEO of the 199 group of companies, he leads an ambitious mission to extend both healthspan and lifespan by 30+ years within this decade.

A serial entrepreneur with over 15 years in aging research, Boris has built a comprehensive ecosystem spanning research, manufacturing, and clinical care. His flagship venture, 199 Biotechnologies, pioneers breakthrough therapies using partial cellular reprogramming to reverse aging at the epigenetic level. Through 199 Labs, with facilities in Hong Kong, Shenzhen, and Singapore, he drives innovation in gene therapy and peptide production, ensuring rapid translation from bench to bedside.

His entrepreneurial vision extends to direct patient care through the 199 Longevity Clinic, where world-class scientists deliver personalized protocols based on cutting-edge diagnostics and evidence-based interventions. This integrated approach—combining deep research, advanced manufacturing, and premium clinical application—creates a powerful feedback loop that accelerates innovation while generating real-world validation.

Boris's collaborative approach includes strategic partnerships with pioneers like TripleHelix, pushing the boundaries of gene therapy applications. As an investor in his own ventures, he brings unique perspectives to biotechnology, leveraging his global experience across Europe and Asia to democratize longevity technologies. With 8 patents in development and multiple compounds in clinical pipeline, he champions a "first-to-market" strategy driven by a moral imperative: patients cannot afford to wait.

Boris represents a new generation of biotech leaders—entrepreneurs who combine scientific rigor with business acumen to tackle humanity's greatest challenges. His work at the intersection of AI and longevity positions him at the forefront of a revolution that promises to make extended healthspan and lifespan a right, not a privilege.